4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-000218
Chief Development Officer acquired 249 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bigora Sian Chief Development Officer | 2026-01-01 | Option exercise | +249 | 1,604 | D | ||
| Derivatives | |||||||
| Bigora Sian Chief Development Officer | 2026-01-01 | Option exercise · Restricted Stock Units | −249 | 0 | D | ||
Loading xslF345X05/form4.xml…